Joseph Palamar, PhD, MPH
NYU Langone Health - Associate Professor, Department of Population Health
Email: joseph.palamar@nyu.edu
Education
PhD, Public Health, New York UniversityMPH, Public Health, New York University
MA, Educational Psychology, New York University
BA, Forensic Psychology, John Jay College of Criminal Justice
Research Interests
Epidemiology of illicit drug use, club drugs, new psychoactive substances, stigma, risky sexual intercourse BIO
Joseph Palamar’s research and publication record reflect his commitment to investigate the epidemiology of drug use. He has a diverse background in psychology, epidemiology, and in the study of drug use, and specializes in psychosocial correlates of drug use. He has focused heavily on the epidemiology of new psychoactive substance use, “club drug” use, and drug-related risky sexual behavior — especially within the electronic dance music (EDM) nightclub and festival scene. He also has extensive experience analyzing data from large national datasets such as Monitoring the Future and the National Survey on Drug Use and Health. Projects
Principal Investigator, Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects. Active
Principal Investigator, New Psychoactive Substance Exposure among NYC Nightclub and Festival Attendees. Active
Principal Investigator, Novel Methods for Estimating the Prevalence of Drug Use among Older Adults. Active
Principal Investigator, Development of a Rapid Survey to Detect Use of New and Emerging Drugs. Completed
Principal Investigator, Drug Use Among Nightclub and Dance Festival Attendees in New York City. Completed
Principal Investigator, Pilot Study Examining the Sexual Effects of Cannabis Use. Completed
Principal Investigator, Pilot Study to Collect Saliva and Follow-up Survey Response Rates among EDM Party Attendees. Completed
Principal Investigator, Use of Psychoactive Drugs and Sexual Risk Behavior among Nightclub and Festival Attendees. Completed
Publications
Recent
Palamar JJ, Rutherford C, Keyes KM (2024).
Diversion of undistributed pharmaceutical ketamine in the US
JAMA [Epub 2024 Dec 5]. doi: 10.1001/jama.2024.23014. PMCID: PMC11622103.
Diversion of undistributed pharmaceutical ketamine in the US
JAMA [Epub 2024 Dec 5]. doi: 10.1001/jama.2024.23014. PMCID: PMC11622103.
Palamar JJ, Krotulski AJ (2024).
Medetomidine infiltrates the US illicit opioid market
JAMA, 332 (17), 1425-1426. doi: 10.1001/jama.2024.15992. PMCID: PMC11537807.
Medetomidine infiltrates the US illicit opioid market
JAMA, 332 (17), 1425-1426. doi: 10.1001/jama.2024.15992. PMCID: PMC11537807.
Han BH, Yang KH, Moore AA, Palamar JJ (2024).
Current cannabis use among adults with heart disease in the USA, 2021-2022
Journal of General Internal Medicine, 39 (15), 3093-3095. doi: 10.1007/s11606-024-08977-3. PMCID: PMC11576699.
Current cannabis use among adults with heart disease in the USA, 2021-2022
Journal of General Internal Medicine, 39 (15), 3093-3095. doi: 10.1007/s11606-024-08977-3. PMCID: PMC11576699.
Palamar JJ, Rutherford C, Le A, Keyes KM (2024).
Seasonal variation of use of common psychedelics and party drugs among nightclub/festival attendees in New York City
Journal of Psychoactive Drugs, 56 (4), 467-474. doi: 10.1080/02791072.2023.2240322. PMCID: PMC10879452.
Seasonal variation of use of common psychedelics and party drugs among nightclub/festival attendees in New York City
Journal of Psychoactive Drugs, 56 (4), 467-474. doi: 10.1080/02791072.2023.2240322. PMCID: PMC10879452.
Palamar JJ, Fitzgerald ND, Goldberger BA, Cottler LB (2024).
Monitoring illicit pentobarbital availability in the United States: A National Drug Early Warning System briefing
Drug and Alcohol Dependence, 263, 112402. doi: 10.1016/j.drugalcdep.2024.112402. PMCID: PMC11384643.
Dr. Palamar's MyBibliography Profile
Monitoring illicit pentobarbital availability in the United States: A National Drug Early Warning System briefing
Drug and Alcohol Dependence, 263, 112402. doi: 10.1016/j.drugalcdep.2024.112402. PMCID: PMC11384643.
Selected Press